{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:26:49Z","timestamp":1792610809112,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ijantimicag.2017.04.019","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T20:02:57Z","timestamp":1498680177000},"page":"447-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Suppressive antibiotic therapy with oral doxycycline for Staphylococcus aureus prosthetic joint infection: a retrospective study of 39 patients"],"prefix":"10.1016","volume":"50","author":[{"given":"M.","family":"Pradier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Robineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Titecat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Blondiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lo\u00efez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Beltrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"D\u00e9zeque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Migaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Senneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0010","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.2106\/JBJS.K.01417","article-title":"Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection","volume":"94","author":"Parvizi","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2017.04.019_bib0035","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0020-1383(11)70126-7","article-title":"Pharmacological agents for soft tissue and bone infected with MRSA: which agent and for how long?","volume":"42","author":"Thompson","year":"2011","journal-title":"Injury"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00614205","article-title":"Serum level, half-life and apparent volume of distribution of doxycycline in geriatric patients","volume":"30","author":"Bocker","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0045","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3122\/jabfm.2011.05.110073","article-title":"Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) Study","volume":"24","author":"Forcade","year":"2011","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0050","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0055","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/jac\/dkp107","article-title":"One hundred and twelve infected arthroplasties treated with \u2018DAIR\u2019 (debridement, antibiotics and implant retention): antibiotic duration and outcome","volume":"63","author":"Byren","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0060","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar3491","article-title":"Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects","volume":"13","author":"Smith","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/514951","article-title":"Prolonged suppressive antibiotic therapy for infected orthopedic prostheses","volume":"27","author":"Segreti","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.blo.0000087321.60612.cf","article-title":"Long-term suppression of infection in total joint arthroplasty","volume":"414","author":"Rao","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0883-5403(88)80075-5","article-title":"Prolonged suppression of infection in total hip arthroplasty","volume":"3","author":"Goulet","year":"1988","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0085","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3928\/0147-7447-19910801-07","article-title":"Suppressive antibiotic therapy in chronic prosthetic joint infections","volume":"14","author":"Tsukayama","year":"1991","journal-title":"Orthopedics"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0090","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijid.2014.09.012","article-title":"Outcome of patients over 80 years of age on prolonged suppressive antibiotic therapy for at least 6 months for prosthetic joint infection","volume":"29","author":"Prendki","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0095","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2106\/JBJS.N.00999","article-title":"Chronic suppression of periprosthetic joint infections with oral antibiotics increases infection-free survivorship","volume":"97","author":"Siqueira","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/IPC.0b013e31816d2118","article-title":"Suppressive antibiotic therapy for retained infected prosthetic joints: case series and review of the literature","volume":"16","author":"Koeppe","year":"2008","journal-title":"Infect Dis Clin Pract (Baltim Md)"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0105","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1469-0691.2007.01691.x","article-title":"Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid","volume":"13","author":"Aboltins","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","article-title":"A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention","volume":"56","author":"Lora-Tamayo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0115","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/j.1469-0691.2010.03333.x","article-title":"Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy","volume":"17","author":"Cobo","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/cir402","article-title":"Outcome and predictors of treatment failure in total hip\/knee prosthetic joint infections due to Staphylococcus aureus","volume":"53","author":"Senneville","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0125","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/529436","article-title":"Treatment of joint prosthesis infection in accordance with current recommendations improves outcome","volume":"46","author":"Betsch","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0130","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jama.1980.03310100021021","article-title":"Minocycline-induced pigmentation at sites of cutaneous inflammation","volume":"244","author":"Fenske","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00002018-200023040-00006","article-title":"Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data","volume":"23","author":"Lawrenson","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5152\/tjg.2014.5415","article-title":"G\u00fcl\u015fen MT. Drug-induced esophageal ulcers: case series and the review of the literature","volume":"25","author":"Da\u011f","year":"2014","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/antibiotics4020216","article-title":"Doxycycline and tigecycline: two friendly drugs with a low association with Clostridium difficile infection","volume":"4","author":"Hung","year":"2015","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/cis457","article-title":"Does doxycycline protect against development of Clostridium difficile infection?","volume":"55","author":"Doernberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.019_bib0155","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/1060028014528792","article-title":"Role of doxycycline in Clostridium difficile infection acquisition","volume":"48","author":"Turner","year":"2014","journal-title":"Ann Pharmacother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T06:01:29Z","timestamp":1692856889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0924857917302285"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.04.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppressive antibiotic therapy with oral doxycycline for Staphylococcus aureus prosthetic joint infection: a retrospective study of 39 patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}